Search Results - "Bode, Alois"

Liposomes as carriers for colchicine-derived prodrugs: Vascular disrupting nanomedicines with tailorable drug release kinetics by Crielaard, Bart J., van der Wal, Steffen, Le, Huong Thu, Bode, Aloïs T.L., Lammers, Twan, Hennink, Wim E., Schiffelers, Raymond M., Fens, Marcel H.A.M., Storm, Gert

“…Newly formed tumor vasculature has proven to be an effective target for tumor therapy. A strategy to attack this angiogenic tumor vasculature is to initiate…”
Get full text

Directed Modulation of Protein KinaseC Isozyme Selectivity with Bisubstrate-Based Inhibitors by vanWandelen, Loek T. M, vanAmeijde, Jeroen, Mady, Ahmed S. A, Wammes, Angelique E. M, Bode, Alois, Poot, Alex J, Ruijtenbeek, Rob, Liskamp, Rob M. J

“…Kinases present an attractive target for drug development, since they are involved in vital cellular processes and are implicated in a variety of diseases,…”
Get full text

Directed Modulation of Protein Kinase C Isozyme Selectivity with Bisubstrate-Based Inhibitors by van Wandelen, Loek T. M., van Ameijde, Jeroen, Mady, Ahmed S. A., Wammes, Angelique E. M., Bode, Alois, Poot, Alex J., Ruijtenbeek, Rob, Liskamp, Rob M. J.

“…Kinases present an attractive target for drug development, since they are involved in vital cellular processes and are implicated in a variety of diseases,…”
Get full text

Inside Cover: Directed Modulation of Protein KinaseC Isozyme Selectivity with Bisubstrate-Based Inhibitors (ChemMedChem 12/2012) by vanWandelen, Loek T. M, vanAmeijde, Jeroen, Mady, Ahmed S. A, Wammes, Angelique E. M, Bode, Alois, Poot, Alex J, Ruijtenbeek, Rob, Liskamp, Rob M. J

Get full text

Inside Cover: Directed Modulation of Protein Kinase C Isozyme Selectivity with Bisubstrate-Based Inhibitors (ChemMedChem 12/2012) by van Wandelen, Loek T. M., van Ameijde, Jeroen, Mady, Ahmed S. A., Wammes, Angelique E. M., Bode, Alois, Poot, Alex J., Ruijtenbeek, Rob, Liskamp, Rob M. J.

Get full text